V028-7288 Screening compound: 2-(N-methyl-1-{5-[(3-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)-N-[(pyridin-2-yl)methyl]acetamide

V028-7288 Screening compound: 2-(N-methyl-1-{5-[(3-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)-N-[(pyridin-2-yl)methyl]acetamide
V028-7288 Screening compound: 2-(N-methyl-1-{5-[(3-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)-N-[(pyridin-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-7288
2-(N-methyl-1-{5-[(3-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)-N-[(pyridin-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-7288

Molecular Formula

C25H28N6O3 (C25 H28 N6 O3)

Compound Name

2-(N-methyl-1-{5-[(3-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)-N-[(pyridin-2-yl)methyl]acetamide

IUPAC name

2-(N-methyl-1-{5-[(3-methylphenyl)methyl]-4-oxo-4H5H6H7H8H-pyrazolo[15-a][14]diazepin-2-yl}formamido)-N-[(pyridin-2-yl)methyl]acetamide

SMILES

Cc1cccc(CN(CCCn(c2c3)nc3C(N(C)CC(NCc3ncccc3)=O)=O)C2=O)c1

InChI

InChI=1S/C25H28N6O3/c1-18-7-5-8-19(13-18)16-30-11-6-12-31-22(25(30)34)14-21(28-31)24(33)29(2)17-23(32)27-15-20-9-3-4-10-26-20/h3-5,7-10,13-14H,6,11-12,15-17H2,1-2H3,(H,27,32)

InChI Key

IKIKHYQWSXTVRA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19907591

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

460.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.464

Distribution Coefficient, logD

1.463

Water Solubility, LogSw

-2.10

Polar Surface Area

80.547

Acid Dissociation Constant (pKa)

13.04

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

V028-7288 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with V028-7288 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-7288?
Check Price and Availability of V028-7288, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-7288 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-7288
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-7288
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-7288 available by request